ASX - By Stock
|
A2M |
Re:
Ann: 1H24 Results Presentation
|
|
Kkkw
|
71 |
27K |
5 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
71
|
27K
|
5
|
|
ASX - By Stock
|
A2M |
Re:
Ann: Becoming a substantial holder
|
|
Kkkw
|
39 |
12K |
3 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
39
|
12K
|
3
|
|
ASX - By Stock
|
IEL |
Re:
Ann: H1 FY24 Investor Presentation
|
|
Kkkw
|
21 |
8.6K |
0 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
21
|
8.6K
|
0
|
|
ASX - By Stock
|
SEK |
Re:
Ann: FY2024 Half Year Results Presentation
|
|
Kkkw
|
7 |
2.1K |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
7
|
2.1K
|
1
|
|
ASX - By Stock
|
IEL |
Re:
Ann: H1 FY24 Investor Presentation
|
|
Kkkw
|
21 |
8.6K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
21
|
8.6K
|
0
|
|
ASX - By Stock
|
IEL |
Re:
Ann: H1 FY24 Investor Presentation
|
|
Kkkw
|
21 |
8.6K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
21
|
8.6K
|
0
|
|
ASX - By Stock
|
IEL |
Re:
Ann: H1 FY24 Investor Presentation
|
|
Kkkw
|
21 |
8.6K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
21
|
8.6K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
THE SQUEEZE IS ON
|
|
Kkkw
|
1.7K |
607K |
0 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
1.7K
|
607K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
THE SQUEEZE IS ON
|
|
Kkkw
|
1.7K |
607K |
2 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
1.7K
|
607K
|
2
|
|
ASX - By Stock
|
IEL |
Re:
MYEFO
|
|
Kkkw
|
28 |
11K |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
28
|
11K
|
1
|
|
ASX - By Stock
|
DYL |
Re:
THE SQUEEZE IS ON
|
|
Kkkw
|
1.7K |
607K |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
1.7K
|
607K
|
1
|
|
ASX - By Stock
|
DYL |
Re:
THE SQUEEZE IS ON
|
|
Kkkw
|
1.7K |
607K |
0 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
1.7K
|
607K
|
0
|
|
ASX - By Stock
|
IEL |
Re:
MYEFO
|
|
Kkkw
|
28 |
11K |
2 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
28
|
11K
|
2
|
|
ASX - By Stock
|
DYL |
Re:
Watcher / research
|
|
Kkkw
|
29 |
9.5K |
0 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
29
|
9.5K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Customer update and FY23 preliminary results
|
|
Kkkw
|
368 |
103K |
2 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
368
|
103K
|
2
|
|
ASX - By Stock
|
UPD |
Re:
Revenue guidance
|
|
Kkkw
|
239 |
191K |
1 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
239
|
191K
|
1
|
|
ASX - By Stock
|
RMD Medicine |
Re:
Buy RMD now and get great upside returns in a year or two
|
|
Kkkw
|
121 |
78K |
2 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
121
|
78K
|
2
|
|
ASX - By Stock
|
IEL |
Re:
MYEFO
|
|
Kkkw
|
28 |
11K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
28
|
11K
|
0
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Raiden secures 100% of LCT & Ni-Cu-PGE Mineral Rights
|
|
Kkkw
|
28 |
12K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
28
|
12K
|
0
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Raiden enters strategic partnership with FQM at Mt Sholl
|
|
Kkkw
|
175 |
77K |
2 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
175
|
77K
|
2
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Funds raised through At the Market Facility
|
|
Kkkw
|
62 |
25K |
0 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
62
|
25K
|
0
|
|
ASX - By Stock
|
RMD Medicine |
Re:
Buy RMD now and get great upside returns in a year or two
|
|
Kkkw
|
121 |
78K |
3 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
121
|
78K
|
3
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
Kkkw
|
24K |
12M |
6 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
24K
|
12M
|
6
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
Kkkw
|
24K |
12M |
0 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
24K
|
12M
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Chart Update
|
|
Kkkw
|
24K |
12M |
7 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
24K
|
12M
|
7
|
|
ASX - By Stock
|
A2M |
Re:
Ann: 2023 Annual Meeting
|
|
Kkkw
|
42 |
8.0K |
6 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
42
|
8.0K
|
6
|
|
ASX - By Stock
|
A2M |
Re:
Ann: 2023 Annual Meeting
|
|
Kkkw
|
42 |
8.0K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
42
|
8.0K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
Ann: 2023 Annual Meeting
|
|
Kkkw
|
42 |
8.0K |
0 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
42
|
8.0K
|
0
|
|
ASX - By Stock
|
A2M |
Re:
Media Updates
|
|
Kkkw
|
14K |
6.9M |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
14K
|
6.9M
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Exceptional lithium results & additional spodumene XRD
|
|
Kkkw
|
143 |
59K |
0 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
143
|
59K
|
0
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Exceptional lithium results & additional spodumene XRD
|
|
Kkkw
|
143 |
59K |
0 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
143
|
59K
|
0
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Exceptional lithium results & additional spodumene XRD
|
|
Kkkw
|
143 |
59K |
1 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
143
|
59K
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Exceptional lithium results & additional spodumene XRD
|
|
Kkkw
|
143 |
59K |
4 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
143
|
59K
|
4
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Raiden acquires 100% of Lithium rights at Arrow Project
|
|
Kkkw
|
80 |
34K |
3 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
80
|
34K
|
3
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Raiden acquires 100% of Lithium rights at Arrow Project
|
|
Kkkw
|
80 |
34K |
3 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
80
|
34K
|
3
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Raiden acquires 100% of Lithium rights at Arrow Project
|
|
Kkkw
|
80 |
34K |
6 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
80
|
34K
|
6
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Raiden acquires 100% of Lithium rights at Arrow Project
|
|
Kkkw
|
80 |
34K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
80
|
34K
|
2
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Pegmatites and Spodumene Mapped at Arrow Project
|
|
Kkkw
|
70 |
30K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
70
|
30K
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
Kkkw
|
5.7K |
2.2M |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
5.7K
|
2.2M
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
Kkkw
|
5.7K |
2.2M |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
5.7K
|
2.2M
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
Kkkw
|
5.7K |
2.2M |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
5.7K
|
2.2M
|
3
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
Kkkw
|
5.7K |
2.2M |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
5.7K
|
2.2M
|
3
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
Kkkw
|
5.7K |
2.2M |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
5.7K
|
2.2M
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Options.... RDNOA, RDNO
|
|
Kkkw
|
251 |
100K |
0 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
251
|
100K
|
0
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Pegmatites and Spodumene Mapped at Arrow Project
|
|
Kkkw
|
70 |
30K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
70
|
30K
|
1
|
|
ASX - By Stock
|
A2M |
Re:
A2M
|
|
Kkkw
|
2 |
1.0K |
5 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
2
|
1.0K
|
5
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Kkkw
|
19 |
7.1K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
19
|
7.1K
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Kkkw
|
19 |
7.1K |
1 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
19
|
7.1K
|
1
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
Kkkw
|
5.7K |
2.2M |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
5.7K
|
2.2M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: FDA Letter Requires Patient Instruction Update
|
|
Kkkw
|
293 |
70K |
3 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
293
|
70K
|
3
|
|